Larimar Therapeutics Inc
F:ZA71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Larimar Therapeutics Inc
F:ZA71
|
US |
|
K
|
Kongsberg Maritime ASA
OSE:KMAR
|
NO |
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
V
|
Vale SA
SWB:CVLC
|
BR |
|
Tele2 AB
F:NCYD
|
SE |
|
FSD Pharma Inc
F:0K9A
|
CA |
|
G
|
Gerresheimer AG
XHAM:GXI
|
DE |
|
Kko International SA
PAR:ALKKO
|
BE |
|
W
|
WooDeumGeeFarm Co Ltd
KOSDAQ:403490
|
KR |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
JP |
|
Chitose Internasional Tbk PT
IDX:CINT
|
ID |
|
Nippon Suisan Kaisha Ltd
F:71N
|
JP |
|
LNA Sante SA
PAR:LNA
|
FR |
|
M
|
McDonald's Corp
SGO:MCD
|
US |
Bankruptcy Probability
Larimar Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Larimar Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Larimar Therapeutics Inc
NASDAQ:LRMR
|
395.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
431.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
193.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Larimar Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Larimar Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
